Phase 1 Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 30 and 70 years old
- You have been formally diagnosed with Parkinson's disease using recognised medical diagnostic criteria
- You have had Parkinson's disease for more than 5 years
- Your Parkinson's is at a moderate stage (Hoehn and Yahr stage 2 or 3 when your medication is not working, known as the "OFF" period) (confirm with trial site)
- You are currently taking Parkinson's medication by mouth, but your symptoms are not well enough controlled, or you are having unwanted side effects from your current treatment
- You have no history of, or only mild, involuntary movements caused by levodopa medication (confirm with trial site)
- Your symptoms respond meaningfully when you take a proper dose of levodopa, as assessed by the trial doctor
- Your blood test results meet specific requirements for white blood cells, platelets, liver function, and kidney function (confirm with trial site)
- You are willing and able to give informed consent to take part
Who may not be able to join:
- You have a condition that affects how your immune system works
- A brain MRI scan has shown brain injuries such as shrinkage, stroke, trauma, or abnormal blood vessels
- A specific brain scan (DaT SPECT) shows unusual results in a particular area of the brain (confirm with trial site)
- Any other abnormal findings are found on your brain MRI scan
- You test positive for a gene mutation called GBA
- You have been diagnosed with dementia, shown by a memory and thinking test score below 24 (MoCA test)
- You have a condition affecting blood clotting, or you are at high risk of bleeding
- You test positive for certain viruses or active infections, including hepatitis B, hepatitis C, HIV, HTLV, syphilis, CMV, chickenpox virus, Epstein-Barr virus, or COVID-19
- You are unable to have an MRI scan, for example because you have metal implants, a pacemaker, an MRI-incompatible artificial heart valve, severe claustrophobia, or your body weight is outside the range the MRI machine can accommodate
- You have a known allergy or medical reason that prevents you from taking the study medications: Tacrolimus, Prednisolone, Basiliximab, Cotrimoxazole, or MRI contrast dye
- You are currently receiving or have received another type of cell transplant, including stem cell treatments
- You have or have had cancer, epilepsy, or bleeding in the brain alongside your Parkinson's disease
- You have an uncontrolled or treatment-resistant psychiatric condition such as severe depression, bipolar disorder, or schizophrenia, confirmed by a psychiatrist
- A psychiatrist has determined that you have an intellectual disability that prevents you from fully understanding what the study involves
- You have previously had brain surgery for Parkinson's, such as pallidotomy, thalamotomy, or deep brain stimulation (DBS)
- You are considered too high a risk for surgery due to significant heart, lung, or other serious health conditions
- In the three months before joining, you have taken immunosuppressant drugs, antipsychotic medication, anti-seizure drugs, or blood thinners (unless safely stopped or adjusted); or in the six months before joining, you have received botulinum toxin injections, phenol injections, or similar treatments for muscle spasms
- You have previously used a medication called Apomorphine for Parkinson's
- You have a history of long-term heavy alcohol use or illegal drug use
- You are pregnant, breastfeeding, or unwilling to use contraception during the study
- The trial researchers have any other safety concerns about your participation (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 021-23562000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety; Safety; Feasibility
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.